Rectitude Holdings Ltd Announces Closing of $8 Million Initial Public Offering
SINGAPORE, June 24, 2024 (GLOBE NEWSWIRE) — Rectitude Holdings Ltd (the “Company” or “Rectitude”), a Singapore-based provider of safety equipment […]
Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock
ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative […]
Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Appointed industry veteran, David Webster, as new Chief Commercial Officer Recently upgraded LungFit PH device expands customer base; revenue growth […]
Airship AI Announces Maturity Date Extension Amendment to Senior Secured Convertible Note
REDMOND, Wash., June 24, 2024 (GLOBE NEWSWIRE) — Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a […]
Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions
Results from the CATALYST clinical trial were presented at the American Diabetes Association’s 84thScientific Sessions at a featured plenary session […]
Presidio Property Trust Announces Closing of $1.74 Million Public Offering of Series D Preferred Stock
SAN DIEGO, June 24, 2024 (GLOBE NEWSWIRE) — (NASDAQ: SQFT) Presidio Property Trust, an internally managed, diversified real estate investment […]
National MI Certified as a Great Place to Work for Ninth Consecutive Year
EMERYVILLE, Calif., June 24, 2024 (GLOBE NEWSWIRE) — National Mortgage Insurance Corporation (National MI), the primary operating subsidiary of NMI […]
Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election
SALT LAKE CITY, June 24, 2024 (GLOBE NEWSWIRE) — A significant 40% of Americans report feeling ‘depressed and/or anxious’ around […]
vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by […]
Kaival Brands Announces Closing of $6.0 Million Public Offering
GRANT-VALKARIA, Fla., June 24, 2024 (GLOBE NEWSWIRE) — Kaival Brands Innovations Group, Inc., (NASDAQ: KAVL) (“Kaival Brands”, the “Company”), the […]
